| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Applied Physiology, Vol 79, Issue 1 229-235, Copyright © 1995 by American Physiological Society
ARTICLES |
R. D. Petit, R. R. Warburton, L. C. Ou and N. S. Hill
Division of Pulmonary and Critical Care Medicine, Rhode Island Hospital, Providence, USA.
We previously found that augmentation of polycythemia by exogenous human recombinant erythropoietin (EPO) failed to worsen the severity of hypoxic pulmonary hypertension in rats. We asked whether this unexpected finding was related to reductions in cardiac output, left ventricular end-diastolic pressure, pulmonary vascular resistance, or some combination of these factors. Four groups of Sprague-Dawley rats were studied over a 3-wk period: hypoxic (0.5 ATM) and normoxic animals each injected with EPO (500 U/kg sc thrice weekly) or saline (control animals). As observed previously, we found that pulmonary arterial (PA) pressures and right ventricular hypertrophy were not increased in EPO-treated rats despite significant increases in hematocrit and blood viscosity. Cardiac outputs, blood volumes, and left ventricular end-diastolic pressures were similar in EPO-treated and control rats. Acute PA pressure responses to acute normoxia in hypoxic rats and to acute hypoxia in normoxic rats were similar, suggesting no differences in vasoreactivity. However, lungs isolated from EPO-treated hypoxic rats had lower pulmonary vascular resistance than saline-treated hypoxic rats when perfused with blood from normocythemic donor rats. PA medial thickness and the percentage of muscularized small PAs were significantly lower in EPO-treated hypoxic rats. These results indicate that augmented polycythemia fails to worsen hypoxic pulmonary hypertension in rats because of a decrease in the severity of structural remodeling.
This article has been cited by other articles:
|
|
 |
|
  M. E. van Albada, G. J. du Marchie Sarvaas, J. Koster, M. C. Houwertjes, R. M. F. Berger, and R. G. Schoemaker Effects of erythropoietin on advanced pulmonary vascular remodelling Eur. Respir. J., January 1, 2008; 31(1): 126 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. McLoughlin and I. McMurtry Counterpoint: Chronic Hypoxia-induced Pulmonary Hypertension does not Lead to Loss of Pulmonary Vasculature J Appl Physiol, October 1, 2007; 103(4): 1451 - 1453. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Satoh, Y. Kagaya, M. Nakano, Y. Ito, J. Ohta, H. Tada, A. Karibe, N. Minegishi, N. Suzuki, M. Yamamoto, et al. Important Role of Endogenous Erythropoietin System in Recruitment of Endothelial Progenitor Cells in Hypoxia-Induced Pulmonary Hypertension in Mice Circulation, March 21, 2006; 113(11): 1442 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Fagan, M. Oka, N. R. Bauer, S. A. Gebb, D. D. Ivy, K. G. Morris, and I. F. McMurtry Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L656 - L664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hasegawa, K. F. Wagner, D. Karp, D. Li, J. Shibata, M. Heringlake, L. Bahlmann, R. Depping, J. Fandrey, P. Schmucker, et al. Altered Pulmonary Vascular Reactivity in Mice with Excessive Erythrocytosis Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 829 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Deten, J. Shibata, D. Scholz, W. Briest, K. F Wagner, R. H Wenger, and H.-G. Zimmer Norepinephrine-induced acute heart failure in transgenic mice overexpressing erythropoietin Cardiovasc Res, January 1, 2004; 61(1): 105 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Herget, J. Novotna, J. Bibova, V. Povysilova, M. Vankova, and V. Hampl Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L199 - L208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Pries, B. Reglin, and T. W. Secomb Structural adaptation of microvascular networks: functional roles of adaptive responses Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1015 - H1025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Ivy, I. F. McMurtry, M. Yanagisawa, C. E. Gariepy, T. D. Le Cras, S. A. Gebb, K. G. Morris, R. C. Wiseman, and S. H. Abman Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L1040 - L1048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Wagner, D. M. Katschinski, J. Hasegawa, D. Schumacher, B. Meller, U. Gembruch, U. Schramm, W. Jelkmann, M. Gassmann, and J. Fandrey Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin Blood, January 15, 2001; 97(2): 536 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Walker, T. C. Resta, and L. D. Nelin Nitric oxide-dependent pulmonary vasodilation in polycythemic rats Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2382 - H2389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Ivy, M. Yanagisawa, C. E. Gariepy, S. A. Gebb, K. L. Colvin, and I. F. McMurtry Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L703 - L712. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
